Sonoma Pharmaceuticals, Inc. Modification Agreements

10 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment Agreement to Acquisition Option between More Pharma Corporation and Oculus Technologies of Mexico
Modification Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2016
Amendment No. 1 to Sales Representation Contract between Oculus Innovative Sciences, Inc. and SLA Brands, Inc.
Modification Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2016
Amendment and Termination Agreement among Oculus Innovative Sciences, Inc., Ruthigen, Inc., and Hoji Alimi
Modification Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2015
Post-Merger Agreement Among Oculus Innovative Sciences, Inc. and Pulmatrix, Inc. Regarding Ruthigen, Inc. Obligations
Modification Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2015
Letter Agreement Amending Loan and Security Agreement Between Oculus Innovative Sciences, Inc. and Venture Lending & Leasing VI, Inc.
Modification Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2012
Letter Agreement Amending Loan and Security Agreement Between Oculus Innovative Sciences, Inc. and Venture Lending & Leasing V, Inc.
Modification Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2012
Amendment and Clarification of Engagement Letter between Oculus Innovative Sciences, Inc. and Dawson James Securities, Inc.
Modification Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2009
Amendment No. 1 to Revenue Sharing, Partnership and Distribution Agreement between Oculus Innovative Sciences, Inc. and Vetericyn, Inc.
Modification Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2009
Amendment No. 1 to Supplement to Loan and Security Agreement by and among Oculus Innovative Sciences, Inc., Affiliates, and Venture Lending & Leasing IV, Inc.
Modification Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2007
Amendment to At The Market Offering Agreement between Sonoma Pharmaceuticals, Inc. and Ladenburg Thalmann & Co., Inc.
Modification Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2023